Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma. - Wikidata - awgldk - TriplyDB

Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma.

Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma.

http://www.wikidata.org/entity/Q39221413

about

Time to re-consider the meaning of BRAF V600E mutation in papillary thyroid carcinoma Integrated genomic characterization of papillary thyroid carcinoma Noncoding RNAs in endocrine malignancy Dynamic monitoring of circulating microRNAs as a predictive biomarker for the diagnosis and recurrence of papillary thyroid carcinoma.The roles of the epithelial-mesenchymal transition marker PRRX1 and miR-146b-5p in papillary thyroid carcinoma progression MicroRNA Deregulation in Anaplastic Thyroid Cancer Biology.MicroRNA-mediated networks underlie immune response regulation in papillary thyroid carcinoma.Deregulated expression of Aurora kinases is not a prognostic biomarker in papillary thyroid cancer patients.Association between microRNA polymorphisms and papillary thyroid cancer susceptibility.MiRNA-146b-5p upregulates migration and invasion of different Papillary Thyroid Carcinoma cells Association between the expression of four upregulated miRNAs and extrathyroidal invasion in papillary thyroid carcinoma.MicroRNA profiling of cisplatin-resistant oral squamous cell carcinoma cell lines enriched with cancer-stem-cell-like and epithelial-mesenchymal transition-type features.Association of BRAF V600E Mutation and MicroRNA Expression with Central Lymph Node Metastases in Papillary Thyroid Cancer: A Prospective Study from Four Endocrine Surgery Centers Expression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients.Prognostic Value of MicroRNAs in Preoperative Treated Rectal Cancer.MicroRNA Expression Profiles in Papillary Thyroid Carcinoma, Benign Thyroid Nodules and Healthy Controls.Integrated microRNA, gene expression and transcription factors signature in papillary thyroid cancer with lymph node metastasis.Altered expression of mir-222 and mir-25 influences diverse gene expression changes in transformed normal and anaplastic thyroid cells, and impacts on MEK and TRAIL protein expression.Cancer stem cells as a potential therapeutic target in thyroid carcinoma.Prognostic biomarkers in thyroid cancer.Genomic medicine for cancer prognosis.MicroRNA expression profiles in the management of papillary thyroid cancer.The role of microRNAs in different types of thyroid carcinoma: a comprehensive analysis to find new miRNA supplementary therapies.MiR-195 Inhibits Tumor Growth and Metastasis in Papillary Thyroid Carcinoma Cell Lines by Targeting CCND1 and FGF2.MicroRNAs in the thyroid.MicroRNA-146b: A Novel Biomarker and Therapeutic Target for Human Papillary Thyroid Cancer.MiR-146b-5p functions as a suppressor miRNA and prognosis predictor in non-small cell lung cancer.MicroRNA-146b, a Sensitive Indicator of Mesenchymal Stem Cell Repair of Acute Renal Injury.MicroRNAs as Biomarkers in Thyroid Carcinoma.MicroRNA-335 is downregulated in papillary thyroid cancer and suppresses cancer cell growth, migration and invasion by directly targeting ZEB2.miRNA dysregulation and the risk of metastasis and invasion in papillary thyroid cancer: a systematic review and meta-analysis.MicroRNA‑497 inhibits cellular proliferation, migration and invasion of papillary thyroid cancer by directly targeting AKT3.In Situ Hybridization Analysis of miR-146b-5p and miR-21 in Thyroid Nodules: Diagnostic Implications.WITHDRAWN: Serum miRNA-203 expression, a potential biomarker for recurrence and prognosis in papillary thyroid carcinoma.Bioinformatic analysis of the ssc-miR-146b upstream promoter region.Upregulation of miR-2861 and miR-451 expression in papillary thyroid carcinoma with lymph node metastasis.Individualised Multimodal Treatment Strategies for Anaplastic and Poorly Differentiated Thyroid Cancer.MicroRNA-150 suppresses the growth and malignant behavior of papillary thyroid carcinoma cells via downregulation of MUC4.miR-214 regulates papillary thyroid carcinoma cell proliferation and metastasis by targeting PSMD10 The management of thyroid nodules and cancer in the molecular era

P2860

Q26853261-69273376-BE40-488C-9344-2A003F730C93 Q28251986-49831DBF-3CEC-4184-865A-16AF5515AC1D Q33577889-B1EE0744-07F7-4871-ADA0-9A9D2062D5C5 Q33750895-A6B89050-CC91-4441-A3A9-80046D7AD128 Q33978070-C4BC5EBB-0EF7-4BEE-B8CC-417EAAD75556 Q34119098-68966314-24B7-42B8-90AE-425AF2AD3F91 Q34259271-610E9D96-2344-4852-8414-930C4085C43F Q35217023-C573E1F7-7451-4C1F-A9EF-04DC6345190C Q35883006-D17BCB30-E4EC-4243-93FB-F86B5974F20A Q35925504-092C9DD1-B5E4-474E-B782-6E1BC5113386 Q36738590-042D7D59-12AF-4856-BC2E-BF8203A53DF0 Q36764848-92723C10-6A87-4D22-A4BD-5BE5151A32FB Q36786213-94F19263-7C0C-425E-82DC-5E6AA39FA0B2 Q36804803-90215E83-3E5C-4DDF-B1FD-5BE7DD57DE67 Q36847230-C5FAA2E2-E268-4814-87D7-C418A8989C3C Q36882561-543E3CB1-72B1-4F7E-8920-A1FE6E5B5708 Q37032712-F85766C4-5C06-4FF9-97D1-E8B04C6B1E2A Q37071712-7E12A10D-2E79-4C8A-B845-22B8B0D097BC Q37288044-7302F640-BE51-48B3-8C66-A96074CE3476 Q38184374-4A051C09-D029-4014-8DBB-76AB78280CF1 Q38238835-2FA4E2D5-5A67-434B-A8F7-4F29D4317593 Q38260896-452956BF-AB31-4A47-BC48-285D23B6FAA9 Q38650146-FCBF1AF3-A2F5-4593-85B2-1D6150636763 Q38663358-B7A4D0EC-921B-490D-AD2C-3E815BB8BC5C Q39030847-A9374027-AABD-40B3-8B90-145AD0A2C83B Q39179286-CC367C3E-7601-456B-BD68-0B2164AFB670 Q41180293-3225D882-3DF6-4F1A-BC9B-E6FA185E8138 Q41657651-F2209E1D-DCF6-48A2-A463-58A9264DE8C9 Q42361202-772E2D08-BB7C-49D8-8211-C1DAA865740C Q49670720-B9AE0BCB-3103-4526-BA45-5B4BACF19041 Q50052816-F816D0E3-2392-4550-B9E6-41F2A41241EC Q53093295-E4519295-8A62-4111-A655-5E44A355FD18 Q53583619-E392779E-6C3B-4CBD-9F83-8DEA640F10D3 Q53721428-CFE2F86D-BBBD-44E1-8316-2E9DB40977F7 Q53871707-12B1A880-2D45-4908-8270-E51F106EE2CB Q54262642-E4404535-4E30-4A92-8FBE-2A0EB67AC85A Q54979096-047231B5-70E1-4436-9142-2788BBB15426 Q55119430-680CFDAD-541B-4BFC-B9DD-66074E98CC7E Q57068280-499DAEC7-D73F-49C4-B7D9-D84D45DB7813 Q58453418-C832F04A-372D-4D29-AF74-7ECF3A0A0700

P2860

Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma.

http://www.wikidata.org/entity/Q39221413

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Prognostic implications of miR ...... n papillary thyroid carcinoma.

@en

Prognostic implications of miR ...... n papillary thyroid carcinoma.

@nl

type

label

Prognostic implications of miR ...... n papillary thyroid carcinoma.

@en

Prognostic implications of miR ...... n papillary thyroid carcinoma.

@nl

prefLabel

Prognostic implications of miR ...... n papillary thyroid carcinoma.

@en

Prognostic implications of miR ...... n papillary thyroid carcinoma.

@nl

P1433

Q39221413-16CCAEEB-5540-4B23-A7B7-3B6199C641B4

P1476

Q39221413-2AC98C73-D93D-46CD-A5C4-3163E5C25AE5

P2093

Q39221413-02228056-A743-4CE8-9CD9-99295ABB9021

Q39221413-02862A5F-95F5-48FE-89AE-EBC019CB6F67

Q39221413-21D8952C-5A40-4489-944C-4FBD638BAFC1

Q39221413-4614D7C9-41F0-46A4-A844-8E3696CB8C3B

Q39221413-58BBE2C1-C5E4-4C51-A264-16B79968C99D

Q39221413-90D025A0-7BDA-479C-A06E-E0714AE251B8

Q39221413-B11C4703-C785-4721-9132-143DEBD7749D

Q39221413-D7537177-FEFF-4408-ABA9-AFD33685DFAD

P304

Q39221413-B023E01E-E7A8-4223-81DA-C98A808F7314

P31

Q39221413-3A56C2DE-1B52-4B71-A681-8FE3B80568AC

P356

Q39221413-64C62175-8342-42A5-B4A2-43B134807567

P407

Q39221413-5BB29494-5D68-4916-9CD6-17A8488EC53E

P433

Q39221413-A2C531BD-2BFD-4E3A-8416-901EA15C9A94

P478

Q39221413-DF6B5386-8D4F-4FC3-84D5-18DA3DC15FE2

P577

Q39221413-880E54C5-4B79-47E9-A4AF-584CE6D2A08C

P5875

Q39221413-EBC16D26-594C-4BD8-8624-F27FD83BAE1B

P698

Q39221413-72AF07F4-17CA-4791-BAC1-696AC6A585A9

P356

P1433

The Journal of Clinical Endocrinology and Metabolism

P1476

Prognostic implications of miR ...... n papillary thyroid carcinoma.

@en

P2093

Chao-Cheng Huang

http://www.w3.org/2001/XMLSchema#string

Chen-Kai Chou

http://www.w3.org/2001/XMLSchema#string

Fong-Fu Chou

http://www.w3.org/2001/XMLSchema#string

Hong-Yo Kang

http://www.w3.org/2001/XMLSchema#string

Kuender D Yang

http://www.w3.org/2001/XMLSchema#string

Rue-Tsuan Liu

http://www.w3.org/2001/XMLSchema#string

Ya-Fang Lee

http://www.w3.org/2001/XMLSchema#string

Yueh-Wen Lan

http://www.w3.org/2001/XMLSchema#string

P304

E196-205

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/JC.2012-2666

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

98

http://www.w3.org/2001/XMLSchema#string

P577

2012-12-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233977457

http://www.w3.org/2001/XMLSchema#string

P698

23264400

http://www.w3.org/2001/XMLSchema#string